Outcomes of transcatheter aortic valve implantation for intermediate-risk patients in Australia: the SOLACE-AU trial

References

• Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis. J Am Coll Cardiol. 2012;60(19):1854.
   PubMed Web of Science ®Google Scholar
• Joseph J, Naqvi SY, Giri J, et al. Aortic stenosis: pathophysiology, diagnosis, and therapy. The Am J Med. 2017;130(3):253–263.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607.
   PubMed Web of Science ®Google Scholar
• De Sciscio P, Brubert J, De Sciscio M. Aortic stenosis in Australia: disease prevalence and patient eligibility for aortic valve replacement. Heart, Lung and Circulation. 2015;24:S409.
   Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Euro Heart J. 2017;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Borger MA, Moustafine V, Conradi L, et al. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. The Ann Thorac Surg. 2015;99(1):17–25.
   PubMed Web of Science ®Google Scholar
• Nelson AJ, Montarello NJ, Cosgrove CS, et al. Transcatheter aortic valve implantation: a new standard of care. The Med J Austr. 2018;209(3):136–141.
   PubMed Web of Science ®Google Scholar
• Walters DL, Webster M, Pasupati S, et al. Position statement for the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program. Heart, Lung and Circulation. 2015;24(3):219–223.
   PubMed Web of Science ®Google Scholar
• Fearon WF, Kodali S, Doshi D, et al. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry. JACC:Cardiovasc Interv. 2014;7(11):1245–1251.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198.
   PubMed Web of Science ®Google Scholar
• Thourani VH, Suri RM, Gunter RL, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. The Ann Thorac Surg. 2015;99(1):55–61.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation. 2017;135(25):e1159–e1195.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–1705.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–1715.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349.
   PubMed Web of Science ®Google Scholar
• Webb JG, Altwegg L, Masson JB, et al. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol. 2009;53(20):1855–1858.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Euro J Cardio-Thorac Surg: Offic J Euro Assoc Cardio-Thorac Surg. 2012;42(5):S45–S60.
   PubMed Web of Science ®Google Scholar
• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–292.
   PubMed Web of Science ®Google Scholar
• Viney R, Norman R, King MT, et al. Time trade-off derived EQ-5D weights for Australia. Value in Health: J Int Soc Pharmacoecon Outc Res. 2011;14(6):928–936.
   Google Scholar
• Kularatna S, Byrnes J, Chan YK, et al. Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease. Qual Life Res. 2017;26(12):3399–3408.
   PubMed Web of Science ®Google Scholar
• Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–1798.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Gulino S, Costa G, et al. Pathophysiology, incidence and predictors of conduction disturbances during transcatheter aortic valve implantation. Exp Rev Med Dev. 2017;14(2):135–147.
   PubMed Web of Science ®Google Scholar
• Mihaylova B, Briggs A, O’Hagan A, et al. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20(8):897–916.
   PubMed Web of Science ®Google Scholar
• Wijeysundera HC, Qiu F, Koh M, et al. Comparison of outcomes of balloon-expandable versus self-expandable transcatheter heart valves for severe aortic stenosis. The Am J Cardiol. 2017;119(7):1094.
   PubMed Web of Science ®Google Scholar
• Tan SS, Rutten FF, van Ineveld BM, et al. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10(1):39–45.
   PubMed Web of Science ®Google Scholar